Nautilus Biotechnology, Inc. (NAUT)
USD 1.81
(-8.59%)
USD 1.81
(-8.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 5.7 Million | 3.41 Million | 2.84 Million | 2.34 Million | - | - |
| Gross Profit | -5.7 Million | -3.41 Million | -2.84 Million | -2.34 Million | - | - |
| Operating Expenses | 76.15 Million | 63.61 Million | 50.49 Million | 15.74 Million | 9618.00 | 111.68 Million |
| Selling, General and Administrative Expenses | 28.9 Million | 25.94 Million | 21.14 Million | 3.31 Million | 1622.00 | 111.68 Million |
| Research and Development Expenses | 47.25 Million | 37.67 Million | 29.35 Million | 12.43 Million | 8488.00 | - |
| Other Expenses | - | -122 Thousand | 183 Thousand | 125 Thousand | - | - |
| Cost and Expenses | 76.15 Million | 63.61 Million | 50.49 Million | 15.74 Million | 9618.00 | 111.68 Million |
| Operating Income | -76.15 Million | -63.61 Million | -50.49 Million | -15.74 Million | -10.11 Thousand | -111.68 Million |
| Interest Expense | - | 5.81 Million | - | - | - | - |
| Income Tax Expense | - | 5.81 Million | 2.6 Million | 2.13 Million | -171.31 Thousand | 738.12 Million |
| Earnings before Tax | -63.67 Million | -57.92 Million | -50.31 Million | -15.61 Million | -9618.00 | 626.6 Million |
| Net Income | -63.67 Million | -63.74 Million | -50.31 Million | -15.61 Million | -9618.00 | 626.6 Million |
| Earnings Per Share Basic | -0.51 | -0.51 | -0.60 | -0.52 | -0.00 | 87.18 |
| Earnings Per Share Diluted | -0.51 | -0.51 | -0.60 | -0.52 | -0.00 | 87.18 |
| Weighted Average Shares Outstanding | 124.91 Million | 124.58 Million | 84.46 Million | 29.96 Million | 7.18 Million | 7.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.91 Million | 124.58 Million | 84.46 Million | 29.96 Million | 7.18 Million | 7.18 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -74.3 Million | -54.5 Million | -47.47 Million | -13.27 Million | -9.56 Million | 626.6 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 8.21 Million | - |
| Cost of Revenue | 1.61 Million | 1.59 Million | 1.59 Million | 5.7 Million | 1.59 Million | 1.51 Million |
| Gross Profit | -1.61 Million | -1.59 Million | -1.59 Million | -5.7 Million | 6.62 Million | -1.51 Million |
| Operating Expenses | 19.1 Million | 19.19 Million | 20.01 Million | 70.44 Million | 20 Million | 19.07 Million |
| Selling, General and Administrative Expenses | 6.81 Million | 7.26 Million | 7.6 Million | - | 7.53 Million | 7.07 Million |
| Research and Development Expenses | 12.28 Million | 11.92 Million | 12.41 Million | - | 12.46 Million | 11.99 Million |
| Other Expenses | - | -19 Thousand | - | - | -56 Thousand | 3.19 Million |
| Cost and Expenses | 19.1 Million | 20.78 Million | 21.6 Million | 76.15 Million | 20 Million | 19.07 Million |
| Operating Income | -19.1 Million | -20.78 Million | -21.6 Million | -76.15 Million | -17.02 Million | -15.87 Million |
| Interest Expense | - | - | - | - | 3.09 Million | - |
| Income Tax Expense | 1.04 Million | - | 1.54 Million | - | -3.03 Million | 3.19 Million |
| Earnings before Tax | -16.44 Million | -18.01 Million | -18.73 Million | -63.67 Million | -17.02 Million | -15.87 Million |
| Net Income | -16.44 Million | -18.01 Million | -18.73 Million | -63.67 Million | -17.02 Million | -15.87 Million |
| Earnings Per Share Basic | -0.13 | -0.14 | -0.15 | - | -0.14 | -0.13 |
| Earnings Per Share Diluted | -0.13 | -0.14 | -0.15 | - | -0.14 | -0.13 |
| Weighted Average Shares Outstanding | 125.45 Million | 125.31 Million | 125.13 Million | 124.91 Million | 124.98 Million | 124.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 125.45 Million | 125.31 Million | 125.13 Million | 124.91 Million | 124.98 Million | 124.93 Million |
| Gross Margin | - | - | - | - | 0.81 | - |
| EBIT Margin | - | - | - | - | -2.24 | - |
| Profit Margin | - | - | - | - | -2.07 | - |
| EBITDA | -17.48 Million | -19.19 Million | -20.01 Million | - | -18.41 Million | -19.07 Million |
| Earnings Before Tax Margin | - | - | - | - | -2.07 | - |
ABL
GFPT-R
PAH3
SMSI
FDX
300612